{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "New York",
      "state": "NY",
      "country": "United States",
      "classification": "Class III",
      "openfda": {
        "application_number": [
          "NDA011757"
        ],
        "brand_name": [
          "DEPO-MEDROL"
        ],
        "generic_name": [
          "METHYLPREDNISOLONE ACETATE"
        ],
        "manufacturer_name": [
          "Pharmacia & Upjohn Company LLC"
        ],
        "product_ndc": [
          "0009-3073",
          "0009-3475"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRA-ARTICULAR",
          "INTRALESIONAL",
          "INTRAMUSCULAR",
          "SOFT TISSUE",
          "INTRASYNOVIAL"
        ],
        "substance_name": [
          "METHYLPREDNISOLONE ACETATE"
        ],
        "rxcui": [
          "1743779",
          "1743781",
          "1743855",
          "1743856"
        ],
        "spl_id": [
          "742fcec7-8db3-4cc6-b276-42587a993810",
          "e4917f75-3e1c-4f3c-803d-d9ec65df06c7"
        ],
        "spl_set_id": [
          "9a7b3837-e038-48bf-97e9-78ad463760dc",
          "bf1b104d-85cb-414d-a366-78068c82c883"
        ],
        "package_ndc": [
          "0009-3073-01",
          "0009-3073-03",
          "0009-3475-01",
          "0009-3475-03",
          "0009-3073-22",
          "0009-3073-23",
          "0009-3475-22",
          "0009-3475-23"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "43502P7F0P"
        ]
      },
      "product_type": "Drugs",
      "event_id": "68876",
      "recalling_firm": "Pfizer Inc.",
      "address_1": "235 East 42nd Street",
      "address_2": "N/A",
      "postal_code": "10017-5703",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1537-2014",
      "product_description": "Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/ mL, 1 mL Single-Dose Vial, Rx only, Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, New York NY 10017  NDC 0009-3073-03    DEPO-MEDROL methylprednisolone acetate Injectable Suspension USP, 40 mg per mL,  1 mL Single-Dose Vial, Rx ONLY, Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, New York NY 10017, NOVAPLUS is a registered trademark of Novation, LLC NDC 0009-3073-23",
      "product_quantity": "93,800 vials",
      "reason_for_recall": "Failed pH Specification: A pH result of 2.9 was obtained at the 9 month stability test interval at 25C/60%RH. The registered specification for pH is 3.0 - 7.0",
      "recall_initiation_date": "20140730",
      "center_classification_date": "20140812",
      "termination_date": "20170322",
      "report_date": "20140820",
      "code_info": "Lot  H43272,  H43265 Exp. 09/14"
    }
  ]
}